Tag: STAT+

March 10, 2026

Ron Johnson Investigates FDA Rejections of Rare Disease Treatments

March 10, 2026

FDA’s Prasad Exit: Controversy Over Rare Disease Drug Decisions

March 10, 2026

Novo Nordisk FDA Warning: Side Effect Reporting Issues

March 10, 2026

Antimicrobial Development Declines: Superbug Threat & Pediatric Access Gaps

March 10, 2026

BioNTech Founders to Launch New mRNA Company & FDA Faces Rare Disease Drug Probe

March 10, 2026

BioNTech Founders to Launch New mRNA Company | STAT News

March 10, 2026

Antimicrobial Development Declines: Superbug Threat & Pediatric Access Gaps

March 10, 2026

Hims & Hers: Super Bowl Ad, Semaglutide Lawsuit & FDA Probe

March 9, 2026

Vertex’s Kidney Disease Drug Shows Promise in Trial, Rivals Otsuka & Vera | STAT

March 9, 2026

Universal Health Services to Acquire Talkspace for $835M